Study objective: To review experience with pneumococcal bacteremia at
two Canadian tertiary care centers. Design: Retrospective record revie
w. Setting: Two tertiary acute care teaching hospitals in Winnipeg, Ma
nitoba. Patients: Patients identified with pneumococcal bacteremia dur
ing an 8-year period. Results: Hospital records were reviewed for 534
of 617 patients with pneumococcal bacteremia. The overall case fatalit
y ratio was 70 (13%), varying from 3.2% in children to 43% in those ol
der than 80 years, Twenty-seven (18%) hospitalized children and 68 (23
%) adults required ICU admission. Duration of hospitalization was 14.9
+/-24.9 and 11.0+/-19.1 days for children at the two institutions and
22.5+/-37.6 days and 38+/-93 days for adults, For the 217 viable pneum
ococcal strains studied, 89% were serotypes included in the present 23
-valent vaccine. Documentation of prior vaccination was present for on
ly 9 (1.7%) patients, although 281 (89%) adults and 99 (45%) children
met criteria for vaccination. Conclusions: Mortality in our population
is similar to previous reports, More widespread pneumococcal vaccinat
ion in eligible populations may not only decrease mortality, but may a
lso provide savings through decreased hospital admission and need for
intensive care.